Company Filing History:
2 out of 238 
2 out of 624 
Years Active: 2016-2018
Title: Hee Chun Jeong: Innovator in Pharmaceutical Chemistry
Introduction
Hee Chun Jeong is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating viral diseases. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
His latest patents focus on indanone derivatives, which are pharmaceutically acceptable salts or optical isomers. These patents detail a preparation method for these compounds and their use in pharmaceutical compositions aimed at preventing or treating viral diseases. The indanone derivatives exhibit excellent inhibitory activity against various picornaviruses, including coxsackie-, entero-, echo-, polio-, and rhinoviruses. They also demonstrate low cytotoxicity, making them promising candidates for treating conditions such as poliomyelitis, viral meningitis, and chronic obstructive pulmonary disease, among others.
Career Highlights
Hee Chun Jeong has worked with prestigious institutions, including Katholieke Universiteit Leuven and the Korea Research Institute of Chemical Technology. His research has contributed to advancements in pharmaceutical applications, particularly in the area of antiviral drugs.
Collaborations
Throughout his career, Hee Chun Jeong has collaborated with notable colleagues, including Young Sik Jung and Hae Soo Kim. These partnerships have fostered innovation and development in his research endeavors.
Conclusion
Hee Chun Jeong's work in developing indanone derivatives showcases his commitment to advancing pharmaceutical science. His contributions have the potential to lead to effective treatments for various viral diseases, highlighting the importance of innovation in healthcare.